The approximately 2-acre Lindenville neighborhood project offers investors a shovel-ready multifamily opportunity in one of Northern California’s most supply-constrained rental markets. A fully...
ByThe RegistryFebruary 23, 2026California’s life science industry regained momentum in 2024, reinforcing its position as a global leader in biotechnology, diagnostics and medical device innovation. According...
ByThe RegistryJuly 23, 2025By Kate Snyder A Silicon Valley property on the market for sale since the start of 2023 received significant attention from potential buyers....
ByThe RegistryJune 5, 2024By The Registry Staff Blackstone’s BioMed Realty has clinched a substantial financial deal, securing a $422.2 million loan to refinance a portion of...
ByThe RegistryJanuary 31, 2024By The Registry Staff Silicon Valley could soon see more sales transaction activity with the listing of a seven-building office and R&D campus...
ByThe RegistryJanuary 22, 2024By Kate Snyder One of the country’s leading life science developers has expanded its holdings in South San Francisco where, for years, it...
ByThe RegistryNovember 2, 2022SAN DIEGO–BioMed Realty (“BioMed”), a leading real estate owner and operator for the life science industry, announced today that Amgen will occupy BioMed’s...
ByThe RegistryDecember 9, 2019BioMed Realty also closes a $430 million financing on the first phase of Gateway of Pacific after executing a long-term lease with AbbVie...
ByThe RegistryMarch 20, 2019SAN DIEGO, (March 18, 2019) – BioMed Realty, a Blackstone portfolio company, announced today the acquisition of the Emeryville Center for Innovation, located...
ByThe RegistryMarch 19, 2019By Meghan Hall In a move indicative of big pharma’s interest in the Bay Area’s strong research and development sector, Chicago-based AbbVie Inc....
ByThe RegistryNovember 2, 2018Industry leader, Steve Morton, joins the award-winning architecture and planning firm Forum Studio, expanding the firm’s presence in California with its office on...
ByThe RegistryJanuary 6, 2018Pharmacyclics, Inc., a biopharmaceutical company acquired by AbbVie last year, has added even more space to its research and development footprint in eastern...
Bypublisher8February 24, 2016
Signup for news and special announcements!
You have successfully joined our subscriber list.